Conference Proceedings

An improved benefit-risk profile of duvelisib in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who received >= 2 prior therapies

Marco Montillo, Ian Flinn, Matthew Davids, Peter Hillmen, Julio Delgado, Bryone Kuss, Constantine Tam, Ulrich Jaeger, Paolo Ghia, Stephan Stilgenbauer, Stephanie Lustgarten, David Weaver, Hagop Youssoufian, Florence Cymbalista

LEUKEMIA & LYMPHOMA | TAYLOR & FRANCIS LTD | Published : 2020